Channel Synergy Leverage DiaSorin's distribution expansion, including the McKesson partnership for Liaison Nes, to introduce Luminex research platforms to clinical labs, pharma CROs, and academic customers through co marketing, bundled offerings, and joint sales motions.

Market Diversification Luminex targets multiple growth sectors including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomics and proteomics, and food safety. Tailor go to market motions and pilot programs to each segment, highlighting cross functional value and streamlined workflows.

Regulatory Edge The launch of CE marked assays such as LIAISON QuantiFERON TB Gold Plus II and other product introductions signals regulatory readiness and growth in Europe. Position as a partner for labs expanding testing capacity with compliant, scalable solutions and regional support.

Enterprise Credibility With revenue in the mid hundreds of millions and a sizeable employee base, Luminex is an enterprise buyer with multi site procurement needs. Offer multi year contracts, training, service, and scalable deployment packages to large labs, hospitals and CRO networks.

Differentiated Solutions Operate in a competitive landscape by emphasizing a broad, adaptable platform supporting diverse research and diagnostic applications. Propose co development or customization opportunities with key customers, and leverage existing distributor relationships to accelerate adoption across geographies.